Compare Vaxcyte Inc. Common Stock (PCVX) vs Stellantis N.V. Common Shares (STLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Stellantis N.V. Common Shares trades at $4.28 (market cap $16.51B). The key difference: Stellantis N.V. Common Shares is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| PCVX | STLA | |
|---|---|---|
Market Cap | $10.51B | $16.51B |
Volume | 2,644,694 | 28,274,156 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $12.12 |
52-Week Low | $40.32 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $36.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Stellantis N.V. Common Shares
Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →
